27 results on '"Wirth, Lori J."'
Search Results
2. Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy
3. Dabrafenib vs Dabrafenib + Trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer- Results of a Randomized, Phase 2, Open-Label, Multicenter Trial
4. Screening and Validation of Molecular Targeted Radiosensitizers
5. A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
6. Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
7. Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach
8. SY33-2 New perspectives on the treatment of thyroid cancer: novel drugs for medullary thyroid cancer
9. O10-3 Selpercatinib (LOXO-292) in patients (pts) with RET-altered thyroid cancer
10. Impact of lung metastases on overall survival in the phase 3 SELECT study of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer
11. A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
12. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
13. 57 Local Control Following Combination Hypofractionated Radiotherapy and Pembrolizumab in a Phase II Trial of Recurrent or Metastatic Adenoid Cystic Carcinoma Patients
14. Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer
15. PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck
16. Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial
17. Detection of Circulating BRAF in Patients with Papillary Thyroid Carcinoma
18. DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity
19. Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors
20. Long-term survival after distant metastasis in patients with oropharyngeal cancer
21. Efficacy and Toxicity of Chemoradiotherapy Using Intensity-Modulated Radiotherapy for Unknown Primary of Head and Neck
22. Seeking alternative biological therapies: The future of targeted molecular treatment
23. Induction Chemotherapy in Locally Advanced Head and Neck Cancer: A New Standard of Care?
24. Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy
25. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck
26. Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy
27. P-521 Unresectable pulmonary carcinoid tumors: Response to therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.